Lunit Nets FDA Nod for AI-Powered 3D Breast Tomosynthesis Solution, Lunit INSIGHT DBT
Lunit INSIGHT DBT receives FDA 510(k) clearance, poised to enter the world's largest DBT marketLun
Source: itnonline.com
Stay updated with breaking news from Breast Tomosynthesis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lunit INSIGHT DBT receives FDA 510(k) clearance, poised to enter the world's largest DBT marketLun
It has also obtained its third US FDA 510(k) clearance.
Also: Lunit achieves FDA clearance for 3D imaging that offers faster and increased accuracy of breast cancer diagnoses.
Also, AIM will be collaborating with Stanford Medicine to validate its diagnostic endoscopic AI.
/PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, continues its rapid expansion across...